Logo CliniGene

CliniGene - NoE

European Network for the advancement of Clinical Gene Transfer & Therapy : EC-NoE fostering interaction of all stakeholders in the field in order to facilitate and help harmonise Ethical, Quality, Efficacy and Regulatory Issues.

  • Presentation
    • CliniGene General Presentation
    • Technology platforms
    • Partners & Contacts
    • Publications from CliniGene partners
  • Facilities & Tools
    • GMP Manufacture of GT-Products
    • CliniGene clinical grade GMP registered partners
  • Regulation & Ethics
    • CliniGene comments on EU Guidelines
    • CliniGene publication related to regulation & ethics
    • National (member states, Israel & Switzerland)
    • US regulation
    • NIH guidance on informed consent for gene transfer research
    • EU reference texts in the area of ethics in research
    • International regulation
    • European Medicines Agency
    • CAT meetings
    • CAT Working Party
  • Quality & Safety
    • CliniGene publications related to Quality & Safety
    • Search selected Gene transfer & therapy references database
    • Search published human gene therapy clinical trials database
    • EU Clinical trials Inventory
    • Serious Adverse events related
    • GTSG – vector integration sites in chromosome
  • Meetings
    • Meetings
    • ESGCT annual meeting
    • ASGT meeting
    • Clinical Gene transfer & e-chips conferences
      • General information
      • Programme
      • Abstract Submission
      • Late Registration
      • Meeting venue & Hotels
      • Sponsoring opportunities
      • Press Conference
      • Gala Dinner
      • Contacts
      • Hands-on training
  • Weblinks
  • Home
  • Facilities & Tools
  • CliniGene clinical grade GMP registered partners

Facilities & Tools Topics

  • GMP Manufacture of GT-Products
  • CliniGene clinical grade GMP registered partners

CliniGene clinical grade GMP registered partners

GMP Manufacturing facilities affiliated to the Clinigene FP6 NoE

Gene (and cell) therapy products for the clinic

CliniGene Academic Partners

Institution Country Products

IBET

Oeiras, Portugal RVV; AdV; Genetically modified cells; AAV; Lentis;
EFS Nantes
Nantes, France AAV; AdV;
Genethon
Evry, France RVV; AAV; Lentis;

HUJI - Hadassah Med. School

Jerusalem, Israel Lentis; Genetically modified cells; Oncolytic viruses;
HZI (FhG, Klinikum Braunschweig) 
Braunschweig, Germany Lentis; AdV; Genetically modified cells;
Karolinska Institutet  Stockholm, Sweden
RVV; Non-viral Genetically modified cells;
Mayo Clinic  Rochester, USA
Measles; RVV; AdV; Genetically modified cells
University College London  London, UK
AAV; Lentis;
APHP Paris, France
Genetically modified cells only;
Medizinische Hochschule Hannover Hannover, Germany
Genetically modified cells only;
University of Eastern Finland   Kuopio, Finland
AdV; AAV; Lentis;

CliniGene Industry Partners

Company Country Products
BioReliance Glasgow, UK
AAV; RVV; AdV; plasmids; (in process: Lentis) Quality & Safety Contro
Plasmid Factory  Bielefeld, Germany
Plasmids and Minicircle DNA for GMP & research, e.g. AAV, LV, RNA, iPS, ...
Oxford BioMedica  Oxford, UK
Lentis; RVV;
Transgene  Strasbourg, France
AdV; Pox-viruses:
CellGenix Freiburg, Germany Cell therapy products only

GenIBET

Oeiras, Portugal RVV; AdV; Genetically modified cells; AAV; Lentis;

CliniGene Board members

Institution Country Products
ClinPharm (spin-off Univ. of Oxford) Oxford, UK
AdV
CERHB, Florida Biologics Univ of Florida  Gainesville, USA
AAV; Plasmids
Children’s hospital of Philadelphia  Philadelphia, USA
AAV

 

  • News
  • Current Gene Therapy Weekly
  • Gene Therapy Database
  • Contact us
  • Disclaimer
  • Sitemap

Members access

Login

Forgot Password?

    • Sixth Framework programme
      EC-09 research
      L5HB-CT-2006-010933